HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olaf Witt Selected Research

MicroRNAs (MicroRNA)

6/2014Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing.
7/2013MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma.
4/2012MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olaf Witt Research Topics

Disease

87Neoplasms (Cancer)
05/2024 - 09/2006
30Neuroblastoma
01/2023 - 04/2008
22Medulloblastoma
01/2024 - 02/2009
20Glioma (Gliomas)
04/2024 - 11/2013
12Astrocytoma (Pilocytic Astrocytoma)
01/2023 - 04/2011
9Brain Neoplasms (Brain Tumor)
01/2023 - 07/2013
8Ependymoma
11/2021 - 01/2009
5Glioblastoma (Glioblastoma Multiforme)
01/2023 - 08/2004
5Carcinogenesis
01/2022 - 01/2009
5Tuberous Sclerosis (Bourneville's Disease)
01/2019 - 01/2013
3Disease Progression
01/2023 - 03/2009
3Stomatitis
01/2023 - 01/2013
3Carcinoma (Carcinomatosis)
01/2023 - 07/2008
3Rhabdomyosarcoma
10/2012 - 02/2009
2Anemia
11/2023 - 01/2019
2Typical Teratoid Rhabdoid Tumor
01/2023 - 01/2019
2Genomic Instability
11/2021 - 12/2019
2Neurologic Manifestations (Neurological Manifestations)
01/2020 - 01/2019
2Leukemia
12/2019 - 09/2006
2Sarcoma (Soft Tissue Sarcoma)
04/2018 - 09/2010
2Myeloid Leukemia (Leukemia, Myelocytic)
01/2016 - 09/2006
2Intellectual Disability (Idiocy)
07/2015 - 01/2012
2Neoplasm Metastasis (Metastasis)
04/2012 - 03/2009
2Retinoblastoma (Glioblastoma, Retinal)
06/2008 - 04/2008
1Central Nervous System Neoplasms
11/2023
1Drug-Related Side Effects and Adverse Reactions
01/2023
1Inflammation (Inflammations)
01/2023

Drug/Important Bio-Agent (IBA)

27Histone Deacetylase InhibitorsIBA
01/2024 - 03/2003
18Histone Deacetylases (Histone Deacetylase)IBA
01/2023 - 03/2003
10Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2008
9Mitogen-Activated Protein KinasesIBA
01/2024 - 01/2009
9DNA (Deoxyribonucleic Acid)IBA
01/2023 - 02/2009
7VorinostatFDA Link
01/2021 - 09/2010
6RNA (Ribonucleic Acid)IBA
11/2023 - 08/2012
6ChromatinIBA
01/2023 - 01/2012
6Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2008
5Biomarkers (Surrogate Marker)IBA
09/2021 - 05/2015
5Messenger RNA (mRNA)IBA
11/2019 - 01/2009
5EverolimusFDA Link
01/2019 - 01/2013
4Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020 - 07/2013
4Valproic Acid (Depakote)FDA LinkGeneric
08/2010 - 08/2004
3tovorafenibIBA
03/2024 - 11/2023
3trametinibIBA
11/2023 - 09/2020
3Vincristine (Oncovin)FDA LinkGeneric
09/2023 - 11/2017
3entinostat (MS 275)IBA
05/2023 - 06/2020
3Histones (Histone)IBA
01/2023 - 07/2008
3trans-sodium crocetinate (crocetin)IBA
01/2019 - 01/2016
3TOR Serine-Threonine KinasesIBA
08/2016 - 01/2013
3IsoenzymesIBA
04/2015 - 07/2013
3MicroRNAs (MicroRNA)IBA
06/2014 - 04/2012
2Conditioned Culture MediaIBA
04/2024 - 01/2019
2Drug CombinationsIBA
01/2024 - 10/2020
2dabrafenibIBA
11/2023 - 09/2023
2Tyrosine Kinase InhibitorsIBA
01/2023 - 10/2008
2Phosphotransferases (Kinase)IBA
01/2023 - 01/2020
2N 30IBA
07/2021 - 12/2020
2ErbB Receptors (EGF Receptor)IBA
01/2021 - 10/2008
2ProteomeIBA
01/2021 - 01/2020
2PCI 34051IBA
01/2020 - 12/2018
2NucleotidesIBA
12/2019 - 01/2016
2Formaldehyde (Formol)FDA Link
11/2019 - 05/2015
2ParaffinIBA
11/2019 - 05/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 01/2010
2Differentiation AntigensIBA
01/2018 - 11/2008
2Dactinomycin (Actinomycin)FDA LinkGeneric
11/2017 - 09/2016
2ZincIBA
01/2016 - 05/2013
2Small Interfering RNA (siRNA)IBA
06/2010 - 11/2008
2Cisplatin (Platino)FDA LinkGeneric
10/2008 - 05/2002
2HC toxinIBA
06/2008 - 04/2008
1CytokinesIBA
04/2024
1Creatine Kinase (Creatine Phosphokinase)IBA
11/2023
1Carboplatin (JM8)FDA LinkGeneric
09/2023
1Adenosine Triphosphate (ATP)IBA
05/2023
1tacedinaline (CI 994)IBA
01/2023
1Tumor Viral Antigens (Large T Antigen)IBA
01/2023
1erdafitinibIBA
01/2023
1SenotherapeuticsIBA
01/2023
1Trypan BlueFDA Link
01/2023
1AfatinibIBA
01/2023
1tariquidar (XR9576)IBA
01/2023
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2023
1tyrosine receptor (receptor, tyrosine)IBA
01/2023
1ulixertinibIBA
01/2023
1Dihydrotachysterol (AT 10)IBA
07/2022
1sonidegibIBA
01/2022
1Proto-Oncogene Proteins c-etsIBA
01/2022

Therapy/Procedure

52Therapeutics
05/2024 - 04/2008
15Drug Therapy (Chemotherapy)
01/2024 - 08/2010
4Precision Medicine
01/2023 - 01/2016
4Investigational Therapies (Experimental Therapy)
10/2021 - 01/2016
4Radiotherapy
01/2021 - 08/2010
3Aftercare (After-Treatment)
07/2021 - 01/2016
2Chemoradiotherapy
01/2020 - 03/2009
2Combined Modality Therapy
10/2016 - 08/2010
2Oncolytic Virotherapy
01/2016 - 09/2010
2Transplantation
12/2012 - 11/2011
1Immunotherapy
01/2023
1Heterologous Transplantation (Xenotransplantation)
01/2023
1Duration of Therapy
12/2022
1Operative Surgical Procedures
07/2022